l dopa decarboxylase/дискинезија

Веза се чува у привремену меморију

ЧланциКлиничка испитивањаПатенти

Изаберите тип сортирања

7 резултати

[Bromocriptin in the treatment of progressive stages of Parkinson's disease (author's transl)].

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Forty patients with severe Parkinson's disease (23 men, 17 women) who had been treated for six years with L-dopa-decarboxylase inhibitor, were part of a placebo-controlled double-blind trial to test the effectiveness of bromocriptin. In all patients the effectiveness of L-dopa had been decreasing,

Routine outpatient L-dopa monitoring in elderly patients with Parkinson's disease.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

In an attempt to improve the therapeutic drug management of patients with Parkinson's disease, plasma L-dopa concentrations were measured by high-performance liquid chromatography and related to the post-dose time with reference to an established therapeutic range of 0.3-1.6 mg/l. The response to

[Juvenile Parkinson's disease initially presenting as bulbar incoordination: a case report].

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

We report a case of juvenile Parkinson's disease which initially presented as bulbar incoordination at the age 12. The condition was characterized by dystonia of the upper extremities. The patient was a 14-year-old female. The patient's main symptoms were bulbar dysfunction. Resting and action

Optimum symptomatic control of Parkinson's disease with dopaminergic therapy.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

This paper presents a review of the literature on the therapeutic action and the side effects of the two main dopaminergic agents: L-DOPA/decarboxylase inhibitor (L-DOPA/DI) and bromocriptine (Parlodel used either as monotherapy or in combination in patients with Parkinson's disease. The combination

[Trazodone in involuntary pathologic movements].

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

The authors report an experiment undertaken with trazodone in the treatment of different forms of pathological involuntary movements. Forty-five subjects were treated for two months; 15 were affected with L-DOPA + decarboxylase inhibitor induced dyskinesias, 9 with choreic or choreoathetosic

[Parkinson disease--problems in long-term treatment. Dopamine agonists optimize L-dopa therapy].

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

In a 59-year-old male with a 10 year history of Parkinson's disease, progressive movement disorders occurred under medical treatment (end-of-dose akinesia and peak-dose dyskinesia). Thereupon his treatment was changed to a combination of L-dopa/ decarboxylase inhibitor administered during the day in

Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND Ten-year follow-up results from the Parkinson's Disease Research Group of the United Kingdom trial demonstrated that there were no long-term advantages to initiating treatment with bromocriptine compared with l-dopa in early Parkinson disease (PD). Increased mortality in patients on

Придружите се нашој
facebook страници

Herbal & Natural Medicine

Најкомплетнија база лековитог биља подржана науком

Ради на 55 језика
Биљни лекови потпомогнути науком
Препознавање биљака по слици
Интерактивна ГПС мапа - означите биље на локацији (ускоро)
Читајте научне публикације повезане са вашом претрагом
Претражите лековито биље по њиховим ефектима
Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима